Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive ...
Morning Report is The Hill’s a.m. newsletter. Subscribe here. In today’s issue: ▪ Parties look for shutdown exit ▪ Dems shore up support in VA, NJ ▪ Takeaways from Trump’s ...
Hudson Regional Health threatens shutdown of Hieight University Hospital unless it receives more state assistance.
Kimberly-Clark announces the acquisition of Kenvue, the maker of Tylenol, in a landmark $48.7 billion deal to create a ...
Covey, David Alan Grier, Josh Lawson and Allison Tolman share how "St. Denis Medical" Season 2, premiering Monday, adds character depth.
Evaxion introduces EVX-04, a novel vaccine candidate targeting multiple non-conventional ERV tumor antigens, developed withour AI-Immunology™ platformEVX-04 is a therapeutic cancer vaccine candidate ...
Summit, NJ-based Kenvue shareholders will own about 46% in what is one of the largest corporate takeovers this year.
Publication highlights Deramiocel’s anti-fibrotic activity and describes a validated potency assay supporting quality control and product consistency in late-stage development- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback